| Dr Yen-trang Xuan Vo, DO | |
|
5492 N Ronald Reagan Pkwy Ste 250, Brownsburg, IN 46112-5618 | |
| (317) 852-3851 | |
| (707) 939-6077 |
| Full Name | Dr Yen-trang Xuan Vo |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 5492 N Ronald Reagan Pkwy Ste 250, Brownsburg, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841515574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20A12252 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
In the controversy surrounding the newly developed strains of avian H5N1 flu viruses, scientists and policy makers are struggling with one question in particular: what level of biosafety is best for studying these potentially lethal strains of influenza? In a pair of commentaries, researchers from the Mount Sinai School of Medicine in New York and the University of Michigan argue their different views of how to safely handle H5N1 flu viruses.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
University of Pennsylvania researchers have made another advance in understanding how the brain detects errors caused by unexpected sensory events.
Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.
Scientists at the Gladstone Institutes today are announcing their role in an unprecedented collaboration organized by the National Institutes of Health, which used groundbreaking methods to vastly improve our understanding of bacteria that reside in and on the human body.
› Verified 7 days ago
| Entity Name | Hendricks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
In the controversy surrounding the newly developed strains of avian H5N1 flu viruses, scientists and policy makers are struggling with one question in particular: what level of biosafety is best for studying these potentially lethal strains of influenza? In a pair of commentaries, researchers from the Mount Sinai School of Medicine in New York and the University of Michigan argue their different views of how to safely handle H5N1 flu viruses.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
University of Pennsylvania researchers have made another advance in understanding how the brain detects errors caused by unexpected sensory events.
Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.
Scientists at the Gladstone Institutes today are announcing their role in an unprecedented collaboration organized by the National Institutes of Health, which used groundbreaking methods to vastly improve our understanding of bacteria that reside in and on the human body.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yen-trang Xuan Vo, DO 19270 Sonoma Hwy, Sonoma, CA 95476-5414 Ph: (707) 939-6070 | Dr Yen-trang Xuan Vo, DO 5492 N Ronald Reagan Pkwy Ste 250, Brownsburg, IN 46112-5618 Ph: (317) 852-3851 |
News Archive
In the controversy surrounding the newly developed strains of avian H5N1 flu viruses, scientists and policy makers are struggling with one question in particular: what level of biosafety is best for studying these potentially lethal strains of influenza? In a pair of commentaries, researchers from the Mount Sinai School of Medicine in New York and the University of Michigan argue their different views of how to safely handle H5N1 flu viruses.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
University of Pennsylvania researchers have made another advance in understanding how the brain detects errors caused by unexpected sensory events.
Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.
Scientists at the Gladstone Institutes today are announcing their role in an unprecedented collaboration organized by the National Institutes of Health, which used groundbreaking methods to vastly improve our understanding of bacteria that reside in and on the human body.
› Verified 7 days ago
David Bain, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5492 N Ronald Reagan Pkwy Ste 250, Brownsburg, IN 46112 Phone: 317-852-3851 Fax: 317-852-1246 | |
Mark P Schopper, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1411 S Green St, Suite 130, Brownsburg, IN 46112 Phone: 317-858-4610 Fax: 317-858-4620 | |
Stephanie A. Mccardle, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1411 S Green St, Suite 130, Brownsburg, IN 46112 Phone: 317-858-4610 Fax: 317-858-4620 | |
Stacia L Groover Maltby, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1411 S Green St, Suite 130, Brownsburg, IN 46112 Phone: 317-858-4610 Fax: 317-858-4620 | |
Dr. David E Wilmot, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1411 S Green St, Suite 130, Brownsburg, IN 46112 Phone: 317-858-4610 Fax: 317-858-4620 | |
Michael Steven Pizzato, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 321 E Northfield Dr, Suite 100, Brownsburg, IN 46112 Phone: 317-852-6065 Fax: 317-852-2468 | |
Allison Suzanne Foley, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1411 S Green St, Brownsburg, IN 46112 Phone: 317-852-7700 |